{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:15Z","timestamp":1759336215063,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.gastrohep.2021.05.015","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T11:10:44Z","timestamp":1623496244000},"page":"342-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-pharmacologic direct cost of a simplified strategy with glecaprevir\/pibrentasvir for 8 weeks in na\u00efve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study"],"prefix":"10.1016","volume":"45","author":[{"given":"Juan","family":"Turnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel B.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-6720","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda L.","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yza Nubia","family":"Frias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roque Miguel","family":"G\u00e1lvez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolau","family":"Vallejo-Senra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-3779","authenticated-orcid":false,"given":"Sara","family":"Par\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Santos de Lamadrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Olveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2021.05.015_bib0115","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"Electronic address: easloffice.eu EASL Recommendations on treatment of hepatitis C: FINAL update of the series","volume":"73","author":"European Association for the Study of the Liver","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0120","unstructured":"European Medicines Agency. Maviret. Summary of product characteristics. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/maviret-epar-product-information_en.pdf [Accessed 02 July 2020]."},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0125","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030. Available at: https:\/\/www.who.int\/hepatitis\/publications\/hep-elimination-by-2030-brief\/en\/ [Accessed 11 September 2018]."},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2468-1253(17)30075-4","article-title":"Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study","volume":"2","author":"Grebely","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s12879-017-2775-0","article-title":"The future of viral hepatitis testing: innovations in testing technologies and approaches","volume":"17","author":"Peeling","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0140","first-page":"30173","article-title":"Hepatitis C reflex testing in Spain in 2019: a story of success [published online ahead of print, 2020 May 22]","volume":"S0213\u2013005X","author":"Crespo","year":"2020","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0145","unstructured":"AEEH-AEHVE-GEHEP-SEIMC-SEPD. Diagn\u00f3stico de la hepatitis C en un solo paso. Available at: http:\/\/aeeh.es\/wp-content\/uploads\/2016\/01\/DX1P-AEEH-AEHVE-SEIMC-SEPD-definitivo.pdf [Accessed 19 September 2018]."},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0150","unstructured":"AEEH-SEIMC. Gu\u00edas AEEH\/SEIMC de manejo de la hepatitis C. Available at: http:\/\/aeeh.es\/wp-content\/uploads\/2017\/03\/documento-consenso.pdf [Accessed 19 September 2018]."},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0155","unstructured":"Oblikue Consulting. eSalud - Informaci\u00f3n econ\u00f3mica del sector sanitario. Available at: http:\/\/esalud.oblikue.com\/index.asp [Accessed 20 September 2018]."},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0160","first-page":"41317","article-title":"Ministerio de ciencia, innovaci\u00f3n y universidades. Resoluci\u00f3n de 3 de abril de 2019, del Instituto de Salud Carlos III, O.A., M.P., por la que se establecen los precios p\u00fablicos correspondientes a la prestaci\u00f3n de servicios y actividades del organismo","volume":"96","author":"Agencia Estatal Boletin Oficial del Estado","year":"2019","journal-title":"Bolet\u00edn Oficial del Estado"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0165","unstructured":"National Institue of Statistics. Consumer Price Index. Available at: https:\/\/www.ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736176802&menu=ultiDatos&idp=1254735976607 [Accessed 12 March 2019]."},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2018.02.017","article-title":"Diagnosis and monitoring of HCV infection using the cobas\u00ae HCV test for use on the cobas\u00ae 6800\/8800 systems","volume":"102","author":"Yao","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2018.03.007","article-title":"High SVR12 with 8-week and 12-week glecaprevir\/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis","volume":"69","author":"Puoti","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa1702417","article-title":"Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection","volume":"378","author":"Zeuzem","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2468-1253(18)30341-8","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial","volume":"4","author":"Asselah","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0195","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S1473-3099(17)30496-6","article-title":"Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial","volume":"17","author":"Forns","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2019.10.020","article-title":"Glecaprevir\/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1-6 and compensated cirrhosis: the EXPEDITION-8 trial","volume":"72","author":"Brown","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0205","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/cid\/ciy220","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in patients coinfected with hepatitis C virus and human immunodeficiency virus type 1: the EXPEDITION-2 study","volume":"67","author":"Rockstroh","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0210","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/liv.14320","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in renally impaired patients with chronic HCV infection","volume":"40","author":"Lawitz","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.01.025","article-title":"Real-world effectiveness and safety of glecaprevir\/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis","author":"Lampertico","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2021.05.015_bib0220","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2019.10.010","article-title":"Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial","volume":"72","author":"Dore","year":"2020","journal-title":"J Hepatol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570521001989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570521001989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:44:54Z","timestamp":1759322694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570521001989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0210570521001989"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2021.05.015","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-pharmacologic direct cost of a simplified strategy with glecaprevir\/pibrentasvir for 8 weeks in na\u00efve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2021.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}